Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the safety and efficacy of MT-2990 for treatment of moderate to severe endometriosis-related pain in women with surgically diagnosed endometriosis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03840993
Study type Interventional
Source Mitsubishi Tanabe Pharma America Inc.
Contact
Status Completed
Phase Phase 2
Start date January 15, 2019
Completion date October 5, 2021